Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Georgia sets sights on eliminating hepatitis C

A combination of strong political will, public support and experience gained in HIV prevention and control led to this new programme. The Ministry of Labour, Health and Social Affairs is working with a pharmaceutical manufacturer to provide an initial 5000 courses of DAAs as the first part of the programme, followed by 20 000 treatment courses annually free of charge.

Published
27 July 2015
From
WHO Europe
Treatment cascades show 90-90-90 goal within reach for some – but Eastern Europe lags behind Africa

Global analysis of HIV treatment cascades – the proportions of people diagnosed with HIV, in care, on treatment and virally suppressed – shows that some of the

Published
22 July 2015
By
Keith Alcorn
IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Study also showed that most commonly used measure — CD4 count does not give accurate projection of illness risk.

Published
21 July 2015
From
Science Speaks
START trial provides definitive evidence of the benefits of early HIV treatment

People who start antiretroviral therapy (ART) immediately after HIV diagnosis, while their CD4 cell count is still high, rather than waiting until it falls below 350 cells/mm3

Published
21 July 2015
By
Liz Highleyman
Latin America Has Beaten Down, but not Beaten, HIV/AIDS

The countries of Latin America have partially met the Millennium Development Goal referring to the fight against HIV/AIDS, according to the UNAIDS report on the global epidemic.

Published
20 July 2015
From
IPS News
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

In a bid to push back against payers, Gilead Sciences is limiting enrollment to its patient assistance program for hepatitis C drugs, which helps people obtain the Sovaldi and Harvoni treatments when they lack sufficient insurance coverage or the financial wherewithal to get the medicines otherwise.

Published
20 July 2015
From
Wall Street Journal Pharmalot blog
Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide

Leading figures in the HIV response have endorsed a call for immediate access to antiretroviral therapy for all people upon diagnosis with HIV, on the opening day

Published
20 July 2015
By
Keith Alcorn
World Health Organization to recommend HIV treatment for all

The World Health Organization will issue new HIV treatment guidelines later this year recommending treatment for all, regardless of CD4 cell count, Dr Meg Doherty of the

Published
20 July 2015
By
Keith Alcorn
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

The drug maker is taking this step after finding that some payers, despite receiving discounts in recent months, have continued to restrict patient access to its hepatitis C medicines. As a result, Gilead has been picking up the cost of the medicines for more people it would like seeking patient assistance, according to a July 1 letter sent to patient groups and community health providers, among others.

Published
19 July 2015
From
Wall Street Journal
Improving access to, and completion of, hepatitis C treatment

PHE's latest briefing in the 'Turning evidence into practice' series has practical advice for commissioners and services on improving access to, and completion of, hepatitis C treatment. Preventing blood-borne virus transmission is one of the eight good practice outcomes of the national drug strategy and treating hepatitis C infection is a growing priority for the NHS.

Published
17 July 2015
From
Public Health England
← First12345...94Next →

Filter by country